A visible, targeted high-efficiency gene delivery and transfection strategy

BMC Biotechnology

Table 1 Analysis of the serum CK activity in the four groups ( ± sd, n = 4)

CK(U/L)	EGFP+MB/US	EGFP+US	EGFP+MB	EGFP alone
Experiment before	269 ± 59	284 ± 62	279 ± 64	258 ± 56
During the operation	271 ± 61	291 ± 66	281 ± 70	261 ± 55
End of the experiment	278 ± 60	288 ± 60	284 ± 63	268 ± 61
24 h	264 ± 58	282 ± 62	277 ± 61	267 ± 59
48 h	268 ± 54	279 ± 59	275 ± 60	253 ± 57

ISSN: 1472-6750